He; Xiao Shu

Patent Applications and Registrations

Patent applications and USPTO patent grants for He; Xiao Shu.The latest application filed is for "new aryl imidazoles and related compounds as c5a receptor modulators".

Company Profile

0.14.11

He; Xiao Shu - Branford CT
He; Xiao-shu - Jackson TN
He; Xiao-Shu - Derwood MD
He; Xiao-shu - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aryl imidazoles and related compounds as C5a receptor modulators Grant 8,119,665 - Luke , et al. February 21, 2	2012-02-21
High affinity small molecule C5a receptor modulators Grant 7,271,270 - Thurkauf , et al. September 18, 2	2007-09-18
New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators App 20070208048 - Luke; George P. ; et al.	2007-09-06
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues Grant 7,241,765 - Hutchison , et al. July 10, 2	2007-07-10
High affinity small molecule C5a receptor modulators App 20070027158 - Thurkauf; Andrew ; et al.	2007-02-01
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues App 20060229298 - Hutchison; Alan ; et al.	2006-10-12
High affinity small molecule C5a receptor modulators Grant 6,884,815 - Thurkauf , et al. April 26, 2	2005-04-26
Melanin Concentrating Hormone Receptor Ligands: Substituted 1-benzyl-4-aryl Piperazine Analogues App 20050065162 - Hutchison, Alan ; et al.	2005-03-24
Aryl imidazoles and related compounds as C5a receptor modulators App 20040116424 - Luke, George P. ; et al.	2004-06-17
High affinity small molecule C5a receptor modulators Grant 6,723,743 - Thurkauf , et al. April 20, 2	2004-04-20
Substituted imidazoles as selective modulators of bradykinin B2 receptors App 20030229076 - Rachwal, Stanislaw ; et al.	2003-12-11
Aralkyl diazabicycloalkane derivatives for CNS disorders Grant 6,656,930 - Bowen , et al. December 2, 2	2003-12-02
2-aminoalkylaminoquinolines as dopamine D4 ligands Grant 6,613,901 - He September 2, 2	2003-09-02
Substituted imidazoles as selective modulators of Bradykinin B2 receptors Grant 6,509,366 - Rachwal , et al. January 21, 2	2003-01-21
2-aminoalkylaminoquinolines as dopamine D4 ligands App 20020143019 - He, Xiao-shu	2002-10-03
Substituted imidazoles as selective modulators of bradykinin B2 receptors App 20020115693 - Rachwal, Stanislaw ; et al.	2002-08-22
2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands Grant 6,432,958 - He August 13, 2	2002-08-13
2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands App 20020058666 - He, Xiao Shu	2002-05-16
Novel 1-(N'-(arylalkylaminoalkyl)) aminoisoquinolines: a new class of dopamine receptor subtype App 20020052496 - He, Xiao-Shu ; et al.	2002-05-02
Aralkyl diaxabicycloalkane derivatives for CNS disorders App 20020045624 - Bowen, Wayne D. ; et al.	2002-04-18
2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands Grant 6,288,230 - Chen , et al. September 11, 2	2001-09-11
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands Grant 6,245,768 - He , et al. June 12, 2	2001-06-12
Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders Grant 5,856,318 - Bowen , et al. January 5, 1	1999-01-05
Aralkyl diazabicycloalkane derivatives for CNS disorders Grant 5,679,679 - Bowen , et al. October 21, 1	1997-10-21
Substituted phenserines as specific inhibitors of acetylcholinesterase Grant 5,171,750 - Brossi , et al. December 15, 1	1992-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.